Enamine
Enamine offers end-to-end drug discovery services, from hit generation to preclinical candidate selection. With 360K+ building blocks, 4.5M+ screening compounds, and 64.9B REAL compounds, we support biotech and pharma with integrated chemistry and biology—accelerating discovery while minimizing risks and timelines.
Date, time and room information
May 6, 13:15 - 13:30, room Marriott 1+2
Category
Commercial stage company
Title of the presentation
Introducing Enamine’s Integrated Discovery
Speaker information
| Name | Position | Institution |
|---|---|---|
| Aleksandra Bugera | Business Development | Enamine |
